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The stimulation of resting T  lympbocytes to enter the cell cycle and to initiate 
transcription of a variety of genes encoding growth factors and immune media- 
tors represents both an intriguing model system for exploring transmembrane 
signaling events and a  topic of intrinsic interest to immunologists. Initiation of 
T  cell  proliferation and  differentiation has been  induced through the  use  of 
specific antigens, with plant  lectins such as  PHA or Con A, or via mAbs to a 
variety of cell  surface molecules.  Recent studies have indicated that all  three 
types of stimuli may in fact operate through a common pathway involving the 
T3 (CD3) complex associated with the clonally distributed receptors on T  cells 
(the T3-T cell antigen receptor [Ti] 1 complex). Thus,  it has been  found that 
mAbs to either Ti on human T  cells or to the T3 complex can mimic the effects 
of  antigen and produce a rapid increase in intracytoplasmic calcium concentration 
([Ca'2+]i), IL-2 production, IL-2-R expression, and ultimately, T cell proliferation 
(1-3).  Weiss and  Stobo  (4)  have also  shown an  obligate requirement for the 
coexpression of T3 and the antigen receptor and observed that expression of 
these molecules appears to be required for the activation of a human T  cell line 
by the lectin PHA. 
On human T  ceils,  two additional structures bave been shown to be capable 
of transducing activation signals. A  combination of two mAbs against distinct 
epitopes on the E-rosette receptor (T1 1) can stimulate human T  cells (5). Others 
have shown  that an  mAb against a  44-kD  glycoprotein (the  9.3  antigen), ex- 
pressed  on  the  majority of human  peripheral  T  cells,  can  also  fully activate 
human T  lymphocytes (6) when combined with PMA. It has been proposed that 
triggering  by  the  anti-Tll  mAbs  and  the  mAb  against  the  9.3  antigen  is 
independent of the T3-Ti complex, even though antibody-induced modulation 
of the T3  complex resulted in the blockade of the T11  pathway of activation 
(5). The relationship of the TI l  and 9.3 antigens to the activation produced by 
plant  lectins has  not  been  clearly defined.  However,  O'Flynn et al.  (7)  have 
shown that certain anti-T1 t  mAbs, which by themselves do not activate T  cells, 
can selectively inhibit the rise in [Ca2*]~ induced by PHA, but not Con A or anti- 
T3 mAbs, and have concluded from this observation that PHA binds directly to 
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the T 11 molecule, resulting in mobilization of Ca  z+ and subsequent proliferation. 
Taken  together,  these  results  suggest  the  existence  of  multiple  cell  surface 
molecules capable of initiating intracellular T  lymphocyte signaling events. The 
question of whether they belong to distinct activation pathways or converge on 
a common central mechanism remains unanswered. 
Although mAbs against the murine equivalents of T3, T 11, and 9.3 have not 
as  yet been  described,  we  and  others  (8-10)  have  shown  that  certain  mAbs 
against the T  cell differentiation antigen Thy-I can activate T  cells in a  manner 
similar to that seen with plant lectins, leading to a  polyclonat induction of IL-2 
production,  IL-2-R  expression,  proliferation,  and  a  rapid  increase  in  [Ca2+]i 
(manuscript  in  preparation).  The  ability  of Thy-1  to  initiate  murine  T  cell 
activation is of particular interest in light of its restricted tissue distribution (high 
on T  cells, brain, and certain hematopoietic precursors [11,  12]),  its pattern of 
ontogenetic expression (it appears on the earliest identified intrathymic precur- 
sors but not on their immediate progenitors [13]), and its structure (homologous 
to an  immunoglobulin domain and apparently bound to  the  membrane  via a 
glycolipid tail  [14]).  These  features  of Thy-1  suggest that  this  molecule  may 
represent a  broadly distributed receptor for stimulation of differentiation of a 
variety of cell types.  An increased understanding of the relationship of Thy-1 
structure to its ability to transduce extracellular signals, and of the biochemical 
basis for signal transmission, would therefore seem particularly valuable. 
Our goals were to use mitogenic mAbs against Thy-1 in concert with transfec- 
tion of a cloned Thy-1  gene, first to analyze the precise role of Thy-1  in T  cell 
activation and then to determine the relationship between anti-Thy-l-induced 
activation, and that produced in response to plant lectins or to stimulation via 
the  T3-Ti  complex.  Our  results demonstrate  that Thy-1  can  be  expressed  at 
high levels following transfection of the human T  cell line,Jurkat, and that mAbs 
to Thy-1  activate all Thy-1 + transfectants in the absence of other murine cell 
surface  molecules.  The  failure  of one  Thy-1 +  transfectant  to  produce  IL-2 
following stimulation via the T3-Ti  complex despite a  rise in [Ca2+]i,  provides 
evidence for a multistep signaling process in T  cell activation. 
Materials and Methods 
Cells and Cell Culture Conditions.  The human T cell tumor line Jurkat (15) clone E6.1, 
was generously supplied by Dr. A. Weiss, University of California, San Francisco. EL4, a 
murine T  lymphoma, was obtained from American Type Culture Collection, Rockville, 
MD. CTLL is an IL-2-dependent murine T  cell line, used in a bioassay to measure IL-2 
levels (16). All cells were maintained at 37°C, 7.5% COz in DME with 4.5 g glucose/liter 
supplemented with nonessential amino acids (0.1 mM), sodium pyruvate (1  raM), gluta- 
mine (300 #g/ml), penicillin (100 U/ml), streptomycin (100 •g/ml),  2-mercaptoetbanol (5 
x  10  -2 M), and 10-20% fetal calf serum; gentamicin (100 #g/ml) was added to spheroplast 
fusion cultures. 
Construction  ofa  Thy-l.2  Transfection  Vector.  A  recombinant Charon 28  X bacterio- 
phage library derived from BALB/c DNA was screened with a  mouse Thy-l.l cDNA 
probe generously provided by S.  M. Hedrick and M. M.  Davis (17).  The cDNA clone 
(~800 bp long) was confirmed to encode Thy-l.1 and to contain 5' and 3' untranslated 
regions by partial sequence analysis and restriction mapping. Three different Thy-l.2 
genomic clones were isolated from the genomic library. For transfection experiments, an 
8.1-kb Eco RI fragment derived from one genomic clone and known to contain a complete 
Thy-1.2 gene (18,  19) was ligated into the Eco RI site of the pSV2gpt vector (20) (Fig. 1). GUNTER  ET  AL.  287 
The orientation  of the  Thy-l.2  gene  within  the  vector was determined  by restriction 
mapping. 
Spheroplast  Transfection.  Spheroplasts were produced from E. coli strain  HB101  bac- 
teria harboring the pSV2gpt-Thy-1.2 vector as previously described (21,22). Spheroplasts 
were fused to the E6.1 Jurkat line by the polyethylene glycol method and cultured at  105 
Jurkat cells per well in 96-well microtiter culture dishes. After 48 h cultures were adjusted 
to the final concentration of selective medium (1.0 ~g/ml mycophenolic acid, 250 #g/ml 
xanthine, and 15 #g/ml hypoxanthine). Cultures were fed weekly; growing colonies were 
detected  3-4 wk after fusion, expanded,  and screened  for Thy-l.2  expression by flow 
microfluorimetry (FMF) analysis. All Jurkat colonies that grew out of selection expressed 
Thy-l.2.  These  colonies  were  cloned  at  limiting  dilution  and  reassayed  for  Thy-l.2 
expression  by  FMF.  All Jurkat  clones  have  been  phenotypically  stable  for  Thy-l.2 
expression,  even when  taken  out of selective  media  for as long as  2  mo of continuous 
culture. 
FMF Analysis.  The cell population (! 06) selected for analysis was first incubated with 
an excess of either mAb culture supernatant or ascites for 30 min at 4°C, and then washed 
three times with HBSS containing 0.1%  NaN3 and 3% FCS. The cells were then stained 
with an excess of FITC-conjugated monoclonal mouse anti-rat  K chain antibody (MAR 
18.5) (23) or FITC-conjugated goat anti-mouse Fab antisera (obtained from B.J. Fowlkes, 
National Institutes of Health). The stained cells were then analyzed on an EPICS V flow 
cytometer (Coulter  Electronics,  Inc.,  Hialeah,  FL).  Data  are  displayed  as cell  number 
(abscissa) vs. relative log fluorescence (ordinate). 
RNA and DNA Blot Analysis.  Cytoplasmic RNA and genomic DNA were prepared as 
previously described (24, 25).  10 #g of cytoplasmic RNA from each cell line to be analyzed 
were electrophoresed  on a  1%  agarose-formaldehyde gel,  transferred  to nitrocellulose, 
and hybridized to the nick-translated Thy-1.1 cDNA probe. For DNA blotting,  10 #g of 
genomic DNA from various cell  lines were digested  with  Hind  III restriction  enzyme, 
electrophoresed on a 0.7% agarose gel, denatured, and transferred to nitrocellulose. The 
nitrocellulose-bound  restriction  fragments  were  then  hybridized  to  nick-translated 
pBR322 plasmid DNA. Hybridization and washing conditions were as described previously 
(22). Autoradiographs were produced using intensifier screens at -70 ° for 24-48 h. 
Monoclonal Antibodies.  The properties of G7, a rat mAb to Thy-1 with T cell activating 
properties,  have been previously described (9).  A  mouse cell line producing mAb to the 
human T3 (CD3) complex, OKT3, was obtained from American Type Culture Collection, 
Rockville, MD. AT15E is a rat mAb to Thy-1 (26) which has activating properties (8).  1- 
22,  III-5, and V-8 are mitogenic rat mAbs to Thy-1  (10) and were generously supplied 
by H. R. MacDonald, Laussane, Switzerland. C.305 is an mAb to the antigen receptor on 
Jurkat cells (4) and was kindly provided by A. Weiss, San Francisco CA. 2A3, a rat mAb 
to Thy-1 that was used in immunoprecipitation experiments,  and 3A7 and 3H11, which 
were used in some activation experiments, are mAbs to Thy-1 that have been previously 
described (27). A mixture of anti-Thy-1 mAbs was used in some FMF experiments and in 
negative selection studies.  It consisted of the following rat mAbs: G7,  3A7, 3H11, and 
2A3 (described above), 2D4, and 4D11 (27). A mouse mAb to the Thy-l.2 allele (28) was 
used in one FMF experiment. 
Cell Surface Labeling, Immunoprecipitation,  and SDS-PAGE.  10  s cells were labeled with 
Na~2r'l by lactoperoxidase-catalyzed cell-surface iodination.  Labeled  membrane proteins 
were then extracted with 0.5% Triton X-100 in a 0.05 M Tris, and 0.3 M NaC1 (pH 7.6) 
buffer containing  1 mM  PMSF,  I0 ug/m[  leupeptin,  and  10  mM  iodoacetamide.  For 
immunoprecipitation mAb 2A3 supernatant was reacted with MAR 18.5-Sepharose for 2 
h at 4°C. These antibody-coupled Sepharose beads were then  washed and reacted with 
the cell extract for 1 h at 4°C with continuous agitation.  Immunoprecipitates were then 
washed three times in the same buffer used for membrane protein solubilization, except 
that the Triton X- 100 concentration was reduced to 0.1%. The precipitated samples were 
then boiled for 5  min in buffer containing 5% SDS and 0.1  M  DTT, then subjected to 
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the  gel  was  fixed  in  20%  TCA,  stained  with  Coomassie  blue,  destained,  and  dried; 
autoradiographs were produced using an intensifier screen at -70°C for 24 h. 
Mutagenesis and Selection.  A Thy-l.2-transfectedJurkat clone, 21 C3.2F7, was cultured 
in ethyl methanesulfonate (200 ~g/ml) for 24 h. Cells were taken out of selection media, 
cultured for four additional days, and then were negatively selected by treatment with a 
mixture of anti-Thy-l.2 mAbs (see above) at 1:200 dilution and rabbit complement at 1:5 
dilution. Surviving cells were subsequently treated with the anti-Thy-1 mAb mixture and 
complement two additional times during the next 3 wk of culture. Cells not staining with 
the anti-Thy-1 mixture were sorted by preparative FMF and cloned by limiting dilution. 
IL-2 Production Assay.  Stimulation  of Jurkat or transfected Jurkat cells was done in 
microtiter wells at 105 cells/well. Cells were stimulated with PHA at 1 ~g/ml, the calcium 
ionophore  A23187  at  100  ng/ml,  OKT3  ascites  at  1:1,000  dilution,  C.305  culture 
supernatant at 1:50,  anti-Thy-1 mAb ascites at  1:200, or anti-Thy-1 mAb culture super- 
natant at  1:10.  In all  cases PMA was present at 50 ng/ml.  After 36 h  of culture,  IL-2 
activity was assessed by measuring [3H]TdR uptake of the IL-2-dependent line CTLL in 
response to a 25% concentration of the test supernatants.  Means of triplicate determina- 
tions are given. The standard  errors were usually <10%  of the means.  Neither PHA, 
A23187,  PMA,  nor any of the  mAbs used  in  this  study had  inhibitory or stimulatory 
effects on CTLL. 
Determination of Free Intracytoplasmic Calcium Concentration.  In a modification of the 
method described by Tsien et al. (29), cells were loaded at 5 ×  106/ml in DMEM containing 
10% FCS with a final temperature of 10 ~M Quin 2-AM (Sigma Chemical Co., St. Louis, 
MO) for 30 min.  After being loaded,  the cells were washed two times with  Dulbecco's 
PBS,  resuspended  in  the  same  buffer  to  a  concentration  of  5  x  106/ml,  and  used 
immediately after equilibration at 37°C for 5 rain. Fluorescence intensity was measured 
with a fluorescence spectrophotometer (model LS-5; Perkin-Elmer Corp., Norwalk, CT) 
(excitation  339  nm, emission 492  nm).  The cuvette chamber was maintained at 37°C, 
and the cell suspension was continuously stirred. After addition of MnC12 (5 #M final) to 
quench  the  fluorescence  of any  Quin  2  present  in  the  extracellular  compartment,  a 
baseline was established.  Antibody was added at a  final concentration of 1:100  ascites. 
Minimum fluorescence (F,,,~,,) was determined by lysing the Quin-2 loaded cells with 0.1% 
Triton X-100 in the presence of 4 mM EDTA and sufficient Tris-buffer to raise the pH 
to  8.0  (to  optimize  chelation  of Ca  z÷  by  EDTA).  Maximum  fluorescence  (Fro,x) was 
obtained after adding excess Ca 2+ (CaCl2,  10 mM final).  Approximate values for cytoplas- 
mic free Ca  2+ were calculated by the formula: [Ca2+]i  x  =  115  nM (Fx -  Fn, i.)/(Fmax  -  Fx) 
(29). 
Results 
Expression  of Thy-l.2 in Human Jurkat Cells.  The human Jurkat line E6.1  was 
transfected by spheroplast fusion with the pSV2gpt-Thy-l.2  construct (Fig.  1). 
Expression  of the Eco-gpt  gene  in  transfected  cells enabled  selection and  long- 
term maintainance of cells in the presence of mycophenolic acid, hypoxanthine, 
and xanthine.  Individual growing colonies visible after ~3-4  wk were expanded, 
stained  with a  mixture of anti-Thy-1  mAb, and  screened for Thy-1  expression 
by FMF. A cocktail of mAbs was used to reduce the probability of a false negative 
result in the screening assay, because of the possibility of selective epitope loss in 
transfected human cells. All colonies that grew out of selection medium showed 
strong membrane Thy-1 immunofluorescence. After cloning by limiting dilution, 
individual  clones  were  again  analyzed  for  Thy-1  expression  by  FMF  (Fig.  2 
illustrates  the  results  of a  representative  experiment  of this  type).  The  E6.1 
Jurkat  clone  and  a  transfected  clone,  21C3.2F7,  were  each  stained  separately 
with antibodies against the human T3 complex and against the murine Thy-l.2 
antigen.  The anti-Thy-l.2  mAb did  not  react with  the Jurkat  line above back- GUNTER  ET  AL. 
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FICURE  1.  The pSV2gpt-Thy-l.2 transfection vector was constructed  as described in Ma- 
terials  and  Methods. Eco  RI  and  Hind  Ill  restriction  sites are  indicated  by  RI and  H, 
respectively. The 8.1-kb genomic Eco RI fragment containing the Thy-l.2 gene is indicated 
by the thin  line, with dark boxes denoting  the  location of exons encoding  Thy-l.2. The 
direction  of transcription  is  indicated.  The portion  of the  vector  derived  from pBR322 
containing the ampicillin resistance gene is shown as a thick line. The portions of the vector 
derived from SV40 are shown as stippled, and the Eco-gpt gene is shown by crosshatching. 
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FIGURE  2.  OKT3 and anti-Thy-l.2 staining of Jurkat and a Jurkat Thy-l.2 transfectant. 
The E6.1 clone ofJurkat (A, B) and a Thy-1.2-tranfectedJurkat clone, 21C3,2F7 (C, D), were 
either stained with OKT3 ascites (A, C) or an anti-Thy-l.2 ascites (B, D). FITC-conjugated 
second antibody in the absence of first antibody is shown as a control (  ....  ). 
ground  levels, while it brightly stained  the  transfected clone 21C3.2F7  (Fig.  2, 
B and D). OKT3  staining was approximately equivalent for both the Jurkat and 
the Thy-1-transfected Jurkat clone. This maintenance of T3 expression was seen 
with all  Thy-1  transfectants  (data  not  shown).  Although  fluorescence levels of 
different  mAbs are  difficult  to  compare  quantitatively,  saturating  amounts  of 
mAbs were used in all cases and it appears that the transfected Thy-1.2 gene was 
being expressed at a greater level than the endogenous T3 protein product. This 
was also observed in all other transfected clones studied. 
The expression of Thy-1.2 inJurkat cells was further analyzed by RNA blotting 
(Fig.  3A) and  by immunoprecipitation  (Fig.  3B).  In  Fig.  3A,  equal amounts of 
cytoplasmic RNA from the  murine  T  cell  line CTLL  (lane A),  the E6.1 Jurkat 
line (lane B), and a  Thy-I.2-transfected Jurkat clone (lane C) were electropho- 
resed in formaldehyde agarose gels, transferred to nitrocellulose, and hybridized 290  'Thy-I  EXPRESSION AND  FUNCTION 
FIGURE 3.  Thy-1  mRNA  and protein expression in transfectedJurkat cells. (A) Cytoplasmic 
RNA (10 #g) from the CTLL line (lane a), the E6.1 Jurkat  clone, (lane b), and a Thy-1- 
transfected Jurkat clone 21C3.2F7 clone (lane c)  was electrophoresed on a  1% agarose- 
formaldehyde gel, transferred to nitrocellulose, and hybridized to nick-translated Thy-l.1 
cDNA. The position of the 28 S and 18 S ribosomal RNA bands are indicated. (B) EL4 (lane 
a), Jurkat  (lane b), and a Thy-1 transfected Jurkat clone, 21C3.2F7 (lane c) were surface 
labeled with 1~51 and lysates  prepared from equal number of cells subjected to immunoprecip- 
itation with an anti-Thy-1 mAb bound to Sepharose beads, as described in Materials and 
Methods. Molecular  mass markers (in kilodaltons)  are shown on the left. 
with a  Thy-l.1  cDNA probe.  Using stringent washing conditions after hybridi- 
zation, RNA from the E6.1  nontransfected Jurkat line failed to hybridize, while 
strong hybridization was detected with RNA from the Thy-l.2 transfected cell. 
The  Thy-1  message  from  the  CTLL  and  21C3.2F7  cell  lines  comigrated; 
however, there appeared  to be a  significantly greater amount of Thy-1  mRNA 
in the transfected Jurkat cells compared with CTLL. 
To  analyze the  membrane  expression  of the  Thy-l.2  molecule, cell  surface 
proteins from a  mouse T  cell line, EL4, the E6.1 Jurkat line, and the Thy-l.2 
transfectant 21C3.2F7,  were iodinated, extracted with Triton X-100,  immuno- 
precipitated with an antibody to Thy-1, and analyzed by SDS-PAGE (Fig.  3B). 
A broad band of ~25 kD was seen in precipitates from EL4 (lane A). In addition, 
a band at ~50 kD (p50) and other, less intense bands at higher molecular weights 
were immunoprecipitated. No bands were detectable in immunoprecipitates from 
Jurkat  lysates (lane B).  A  major band of ~25  kD and a  minor band of 50  kD 
were immunoprecipitated from the Thy-1.2-transfectedJurkat cell, both of which 
comigrated with similar bands precipitated from EL-4. The p50 band has been 
previously observed in anti-Thy-1  immunoprecipitates (9) and peptide mapping 
data indicate that p50 may be a dimer of the 25-kD Thy-1  molecule (L6gdberg, 
L., and K. C. Gunter, unpublished data). 
Thy-l-transfected  Jurkat  Cells Express  Some, But Not All,  Thy-1 Epitopes.  We 
have previously described an mAb against the Thy-1  molecule, G7, which could 
induce  iymphokine production  by and proliferation of resting murine T  cells. 
The Jurkat line (E6.1) has been shown to produce IL-2 when reacted with mAbs 
against the T3  complex in combination with PMA (15).  As an initial approach 
to the analysis of the function of Thy-1  in T  cell activation, we intended to test 
whether the Thy-1.2-transfected Jurkat cell would secrete IL-2 when stimulated 
with the mitogenic mAb G7 plus PMA. However, when we analyzed a transfected 
Jurkat clone for G7  binding by  FMF, no staining above background  was seen 
(Fig. 4), although G7 reacted strongly with the murine T  lymphoma, EL4 (data GUNTER ET  AL  291 
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FIGURE 4.  Staining  of Thy-!,2-transFected  Jurkat done with  a panel  of mitogenic  anti-Thy- 
l mAbs. The indicated  mAbs were reacted with  the Thy-1.2-transfectedJurkat  clone  21C3.2F7 
followed by the second antibody, FITC MAR 18.5. FITC-conjugated  second antibody  in the 
absence of first antibody  is shown as a control (  .....  ). 
not shown). G7 has failed to bind to all Thy-l.2-transfected  Jurkat clones tested 
(data not shown). Furthermore, the absence of the G7 epitope is not restricted 
to Jurkat transfectants, because when murine B cell lymphomas or macrophage 
lines were transfected with the same pSV2gpt-Thy-1.2 vector, Thy-1.2 molecules 
were expressed on the cell surface, but G7 failed to bind (manuscript in prepa- 
ration). 
The failure of the transfected cells to express the epitope recognized by mAb 
G7 prompted a more complete survey of transfected Jurkat lines with a panel of 
mitogenic anti-Thy-1  mAb (Fig. 4).  Three out of four such mAbs bound to a 
Thy-l.2-transfected Jurkat cell, while mAb 1-22 failed to bind. The mAbs V-8 
and AT15E showed a broad distribution of fluorescence compared with III-5 or 
the cocktail of rat anti-Thy-1  mAbs. The basis  for this apparent heterogeneity 
of binding is  not  known, although it varied  from experiment to experiment. 
These anti-Thy-1 mAbs also have several differences in their activating properties 
compared with the prototype mAb,  G7.  G7  recognizes both the Thy-l.1  and 
Thy-l.2 alleles, and  has  been  shown  to  stimulate IL-2  secretion  from T  cell 
hybridomas and normal spleen cells.  Furthermore, the G7  mAb can stimulate 
proliferation of resting T  cells from several strains of mice (10).  The 1-22, III-5, 
and  V-8  mAbs  have  been  shown  to  stimulate  macrophage  activating  factor 
secretion from cytolytic T  lymphocyte lines, but only one of these three mAbs 
(III-5) is capable of stimulating IL-2 production by and proliferation of normal 
spleen cells (10). The AT15E mAb does not stimulate resting T cell proliferation 
(9), but elicits 1L-2 production from the EL4 line (8) and can stimulate macro- 
phage activating factor secretion from at least one cytolytic T  lymphocyte clone 
(10). 
Functional  Properties of the Thy-l-expressing Jurkat Cells.  As a correlate to the 
binding experiment described above, one Thy-l.2-transfected Jurkat clone was 
tested for its ability to secrete IL-2 when stimulated with a panel ofanti-Thy-l.2 
mAbs plus PMA (Table I). As seen in this representative experiment, all the anti- 
Thy-1 mAbs that bound to the transfectedJurkat clone stimulated IL-2 secretion 
in the presence of PMA, but had no effect on the nontransfected E6.1  Jurkat 
clone.  In  addition,  the  combination of anti-Thy-1  mAbs  3A7  and  3H11  was 292  Thy-1  EXPRESSION  AND  FUNCTION 
TABLE  I 
Anti-Thy- 1-stimulated IL-2 Production  from Jurkat and 
Thy- l.2-transfected Jurkat 
Stimulus 
Responding cell line 
E6.1  21C3.2F7 
Medium  949  t ,008 
PMA  2,743  2,555 
III-5 +  PMA  5,005  38,018 
V-8 +  PMA  3,924  34,520 
1-22 +  PMA  4,662  1,311 
AT15E +  PMA  3,872  16,141 
G7 +  PMA  2,941  3,401 
3A7 +  3H11  +  PMA  3,864  41,942 
The Jurkat line (E6.1) and a Tby-1.2-transfected clone (21C3.2F7) were 
cultured with anti-Thy-1  mAbs (1:10  supernatant: III-5, V-8, 1-22,  and 
AT15E or 1:200 ascites: G7, 3A7, and 3H11) and/or PMA (50 ng/ml) as 
described in Materials and Methods. Supernatants were harvested and I L- 
2 content was determined by [3H]TdR uptake of an IL-2-dependent cell 
line, CTLL. Data are expressed as mean cpm. 
capable of stimulating IL-2 secretion from the transfectedJurkat cell. These two 
mAbs have been shown to act in a synergistic manner to stimulate normal mouse 
T  cell activation in the presence of PMA, but neither mAb can activate by itself 
(manuscript  in  preparation).  None  of  the  anti-Thy-1  mAbs  was  capable  of 
stimulating IL-2 secretion from the transfected cell in the absence of PMA (data 
not shown). In a similar fashion, OKT3 mAbs do not stimulate appreciable IL-2 
secretion from Jurkat cells in the absence of PMA (15). The activation induced 
by the anti-Thy-1  mAbs was specific because no IL-2 production was observed 
when the transfected Jurkat line was stimulated by any of several mAbs against 
OKT11 in the presence of PMA (results not shown). Similarly, mAbs against T1 
or HLA fail to stimulate the parental  E6.1 Jurkat line (3). 
Having established that the Thy-1.2 molecule retained its functional properties 
when expressed by the Jurkat cell, we were interested in determining  how the 
expression of the introduced gene might affect the normal activation properties 
of the cell. To this end, a panel of five independent, cloned Thy-l.2-transfected 
Jurkat  cell  lines,  derived  from  three  separate  spheroplast  fusions,  were tested 
with a  variety of stimuli (Table II).  As previously demonstrated  (Table I),  the 
combination of rat anti-Thy-1  mAbs, 3A7 and 3H 1 I, was capable of stimulating 
all the Thy-l-bearing Jurkat ceils in the presence of PMA. PHA, OKT3, and an 
anticlonotypic  mAb  (C.305)  which  had  been  previously shown  to activate  the 
Jurkat cell line (4) stimulated both the parental Jurkat cell and four of the five 
Thy-l.2 Jurkat transfectants.  One transfectant (21 C3.2F7) did not secrete I L-2 
when  stimulated  with  anti-T3  or -Ti  mAbs;  21C3.2F7  also made  very low to 
negligible levels of IL-2  in response to PHA, compared with Jurkat and other 
transfected clones. In contrast, 21 C3.2F7 could produce IL-2 in response to the 
calcium ionophore A23187 plus PMA, indicating that it was still  capable of IL- 
2  secretion.  Furthermore,  21C3.2F7  produced  I L-2  in response to anti-Thy-1 
mAbs.  These  results imply  that  the  IL-2  secretory mechanism  of the  clone  is GUNTER  ET  AL. 
TABLE II 
IL-2 Production  from a Panel of Thy-l.2-transfected Jurkat Cell Lines 
293 
Stimulus 
Responding cell line 
E6.1  21C3.2F7  21D6.2C5  J14C9  J19G4  J20F8 
Medium  5,112  4,149  3,012  2,318  4,344  2,126 
PMA  8,341  7,641  9,030  7,328  5,929  4,915 
PHA + PMA  46,708  5,471  43,150  55,995  54,473  46,142 
OKT3 + PMA  32,952  8,396  31,624  48,605  50,552  31,438 
C.305 + PMA  43,485  9,249  44,830  40,082  32,520  24,418 
3HI 1 + 3A7 + PMA  8,945  35,774  40,691  55,564  49,745  20,815 
A23187 + PMA  35,530  33,482  36,438  48,963  31,838  28,75l 
The Jurkat line (E6.-1) and  five Thy-l.2-transfected Jurkat clones were cultured  with PHA (1.0 
ug/ml),  OKT3 (1:1,000 ascites), the anti-Jurkat Ti mAb C.305 (1:50 sup), the anti-Thy-1 mAbs 
3H11 and 3A7 (1:200 ascites), the calcium ionophore  A23187 (100 ng/ml), and/or PMA (50 ng/ 
ml). 2IC3.2F7 and 21 D6.2C5 are separate clones derived from the one spheroplast fusion; J19G4 
and J20F8 were separate clones derived from a second fusion, whileJ14C9 Was derived from a third 
fusion. IL-2 content  of the stimulated supernatants  was measured by [SH]TdR uptake by an IL-2- 
dependent cell line, CTLL. Data are expressed as mean cpm. 




LOG FLUORESCENCE INTENSITY 
FI(;URE  5.  Anti-Thy-1  staining ofaThy-l-transfectedJurkat  clone and a Tby-l- revertant. 
The Thy-l-expressingJurkat transfectant, 21C3.2F7, and its Thy-l- derivative, 21C3N, were 
stained with a mixture of rat anti-Thy-1 mAbs (described in Materials and Methods) and MAR 
18.5 (  ) or with MAR 18.5 alone (  ..... ). 
intact. When stained with antibodies to T3 and Ti, the nonresponder 21C3.2F7 
clone displayed equivalent levels of fluorescence compared with E6.1 Jurkat cells 
and other Tby-l.2-transfected Jurkat clones (Fig.  2, and data not shown).  This 
result  indicates  that  a  quantitative  defect in  expression  of the  T3-Ti  does not 
account for the failure of 21 C3.2F7  to respond to receptor related iigands. 
Derivation  and  Functional Properties of a  Revertant  Thy-1-Jurkat  Clone.  Al- 
though the data presented in Table II suggest that the Jurkat Thy-1 transfectant 
21C3.2F7  was  markedly deficient  in  its ability  to  secrete  IL-2  in  response  to 
some cell surtace  ligand  binding event~, the  possibility remained  that the  func- 
tional phenotype of this cell was merely representative of clonal variation within 
the parental Jurkat population and not due to the integration and expression of 
the  foreign  gene  construct.  To distinguish  between  these  possibilities,  we pro- 
duced  a  Thy-l.2-  revertant to this transfected Jurkat  clone by chemical muta- 
genesis with ethyl methane sulfonate, negative selection using anti-Thy-1  mAbs 
and  complement,  and  cell  sorting.  After  cloning,  one  revertant  (21C3N)  was 
analyzed for surface expression ofTby-1. As shown in Fig. 5, the revertant clone 
did not stain above background levels with a mixture of rat mAbs to Thy-1. The 
staining of the Thy-1.2 + Jurkat clone, from which  21 C3N was derived, is shown 
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To  confirm  that  the  21C3N  clone  was  derived  from  the  nonresponder 
21C3.2F7,  equal  amounts of genomic DNA  from the  two  cell  lines  and  the 
responder  clone  21D6.2F6  were  digested with  Hind  III  restriction  enzyme, 
electrophoresed on agarose gels, and transferred to nitrocellulose. The filters 
were then hybridized with nick-translated pBR322 plasmid DNA (Fig. 6).  Mul- 
tiple bands were present in all three cell lines, indicating that multiple copies of 
the construct were integrated into high molecular weight DNA. The hybridiza- 
tion patterns of DNA from the 21C3N  (lane C) and 21C3.2F7 (lane B) clones 
were identical, indicating that (a) the 21C3N, Thy-1.2- revertant has not deleted 
the  foreign  gene  from  its  genome, and  (b)  that  21C3N  is  derived from  the 
nonresponder  21C3.2F7.  The  hybridization pattern  of the  responder  clone 
21D6.2F6  (lane A) shows less  intense hybridization, indicating a  reduced copy 
number  for  the  Thy-l.2-containing construct.  In  addition,  21D6.2F6  lacks 
several of the bands seen in the other lanes, indicating that it is derived from a 
separate transfection event.  There are  common bands in all  the digests. The 
major band of ~5.5  kb represents an intact internal segment of the pSV2gpt- 
Thy-l.2 construct. The other,  less  bright bands at varying molecular weights 
presumably  represent junctional  fragments derived  from  integration  at  sites 
within the Hind III fragment of the original construct DNA. Thus, this experi- 
ment indicates that the Thy-l.2- line, 21C3N,  still  contains pSV2gpt-Thy-l.2 
in its genome, and furthermore is derived from the Thy-l.2  + line, 21C3.2F7. 
We next conducted experiments to determine if the loss of Thy-1.2 expression 
correlated with any changes in functional phenotype in  21C3N.  In Table III, 
Jurkat, 21C3N, and 21 C3.2F7 are compared in an IL-2 production assay. In this 
representative experiment, the Thy-l.2- 21C3N line, although derived from the 
nonresponder Thy-l.2  + 21C3.2F7  line, responded normally to stimulation by 
FIGURE 6.  Analysis  of pSV2gpt-Thy-l.2 derived DNA in transfectants. 10 tzg of genomic 
DNA from the 21C3.2F7 Thy-l-transfected  clone (lane B), its Thy-1 negative derivative, 
21C3N (lane C), and a separate Thy-1 transfected  Jurkat clone, 21D6.2F6 (lane A), were 
digested with Hind III, electrophoresed  through an 0.7% agarose gel, transferred  to nitrocel- 
lulose, and hybridized  to a nick-translated  pBR322 probe. Molecular  size markers generated 
from phage ~ digestion  with Hind III are shown  on the left. GUNTER  ET  AL.  295 
TABLE III 
IL-2 Production from a Thy-l.2  + Transfectant and a Thy-l.2- 
Revertant Clone 
Stimulus 
Responding cell line 
E6.1  21C3.2F7  21C3N 
Medium  2,043  3,048  4,280 
PMA  4,912  6,991  5,215 
OKT3 +  PMA  89,421  8,233  85,633 
C.305 +  PMA  75,632  7,554  78,491 
3Hll  +  3A7 +  PMA  5,001  61,428  6,095 
A23187 +  PMA  80,643  68,113  60,235 
The Jurkat line (E6.1), a Thy-1.2-expressing transfected line (21 C3.2F7), 
and a derivative of 21C3.2F7  that no longer expresses Thy-l.2 (21C3N) 
were stimulated as indicated and as described in Table II. IL-2 content of 
the stimulated supernatants was measured by [SH]TdR uptake by an IL- 
2-dependent cell line, CTLL.  Data are expressed as mean cpm. 
OKT3  and  antireceptor  mAb  C.305.  As  would be expected,  anti-Thy-1  anti- 
bodies had no effect on either the 21C3N or the E6.1 Jurkat clone. As before, 
the only stimuli capable of inducing IL-2 secretion from the 21 C3.2F7 were anti- 
Thy-1 antibodies and ionophore. Thus, the 21C3N Thy-l.2- revertant line has 
a responder phenotype to stimulation via the T3-Ti complex. 
Dissociation of Increases in [Ca  2÷]i  from Activation for IL-2 Production.  Increases 
in [Ca2+]i have been shown to accompany activation ofT lymphocytes in response 
to mitogenic stimulation (30) and have also been seen in Jurkat cells stimulated 
with  PHA,  OKT3  mAbs,  or  mAbs against  Ti  (3).  Since  the  21C3.2F7  clone 
produced  little  if any  IL-2  when  stimulated  with  mitogenic  mAbs other  than 
anti-Thy-1,  we wished to determine whether this clone would fail to show the 
usual increase in [Ca2+]i that accompanies stimulation with the OKT3 mAb. Fig. 
7A  depicts  the  Quin  2  fluorescence changes  induced  by the  OKT3  mAb  on 
Jurkat  cells (E6.1),  Thy-l.2-transfected  responder  (21 D6.2C5),  Thy- 1.2-trans- 
fected  nonresponder  (21C3.2F7),  and  the  Thy-l.2-  revertant  responder  line 
21C3N.  In all cases OKT3 was able to increase [Ca2+]i from <100 nM to ~400 
riM. Thus, both the 2 ! C3.2F7 nonresponder cell- line, as well as the transfectants 
that produced IL-2 in response to OKT3, showed the increase in [Ca2+]i usually 
associated with  complete cellular  activation.  In  addition,  mAbs against  Thy-1 
were  also  able  to  stimulate  an  increase  in  [Ca2+]i  in  the  Thy-l.2-transfected 
nonresponder (Fig.  7B) and responder (data not shown) Jurkat lines, indicating 
that  increases  in  [Ca2+]i are  common  to  both  the  T3  and  Thy-1  activation 
pathways. These findings suggest that  significant differences in the mechanism 
of stimulation  by anti-Thy-1  and  anti-T3/Ti  mAbs  exist  in  that  a  functional 
dissociation is seen in 21C3.2F7 cells. 
Discussion 
The results reported here demonstrate the expression of murine Thy-1  by a 
transfected human  T  cell tumor, and document the ability of anti-Thy-1  mAbs 
to activate such cells. The Thy-1 gene was introduced into the human Jurkat cell 
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FIGURE 7.  mAb-induced  changes  in intracytoplasmic  calcium  inJurkat and Thy-l-transfected 
Jurkat. The indicated cell lines were loaded with Quin 2-AM, then stimulated with the OKT3 
mAb (A) or 3A7, a mAb to Thy-1 (B). Approximate values  for cytoplasmic  free Ca  2+ are given 
on the vertical axis. 
with OKT3, clonotypic mAbs against its T  cell receptor,  PHA, or the calcium 
ionophore, A23187.  All of these stimuli are also capable of producing a  rapid 
rise in [Ca~+]i in the absence of PMA. Our data demonstrate that high levels of 
Thy-l.2 protein, biochemically similar to that expressed on murine T  cells, are 
present on the cell membrane of  Jurkat after transfection with a Thy 1.2 genomic 
clone.  Although  the  Thy-l.2  molecule  on  the  transfected  cells  lacks  certain 
serologically defined epitopes found on Thy-1 + murine cells, several anti-Thy-1 
mAbs previously shown to activate murine T  cells could be shown to stimulate 
IL-2  production  by the  Thy-1 + Jurkat  transfectants when  used  together  with 
PMA. One Thy-1 + transfectant was unable to respond to stimulation by mAbs 
against T3 or tbe T  cell receptor while it responded vigorously to stimulation by 
anti-Thy.  Both  the Thy-1 + nonresponder line and a  Thy-1  negative revertant 
which  secreted  IL-2  after  stimulation  by  anti-T3  showed  similar  increases  in 
[CaZ+]i  following anti-T3  binding,  thus  dissociating  the  rise  in  [Ca2+]i from 
activation of the IL-2 gene. 
Most mitogenic anti-Thy-1  mAbs (III-5, V-8, AT15E, and 3A7 and 3H11  in 
combination) bound to transfected Jurkat cells and were able to stimulate IL-2 
production. Since none of these mAbs reacted with the parental Jurkat line, we 
can  conclude that the stimulation of the transfected cells was mediated by the 
direct interaction  of the antibody with Thy-1  and  is not  the result  of a  cross 
reaction between determinants on Thy-1  and determinants on the human T3 
complex.  Therefore, it is also  likely that the stimulation of murine T  cells by 
mitogenic anti-Thy mAbs  is also mediated by a  direct  interaction  with Thy-1 
and not secondary to a  cross reaction with determinants present on the murine GUNTER ET  AL.  297 
T3  homologue or the  T  cell  receptor.  However, we do not wish  to conclude 
from  these  observations  that  binding  of the  anti-Thy  mAbs is  the  only event 
necessary to trigger activation. It is possible that there are cell surface molecules 
present  on  both  murine  and  human  cells that  must  interact  with  Thy-I  after 
ligand binding to transmit an activation signal. Two mAbs able to activate murine 
T cells did not bind to Thy-1.2-transfectedJurkat cells. Although the explanation 
for  the  absence  of the  corresponding  epitopes  is  unclear,  the  lack  of these 
determinants  did  not  prevent  activation  through  sites  recognized  by distinct 
mAbs. 
All Jurkat cells that expressed Thy-1.2 were stimulated by mitogenic mAbs to 
Thy-1.  In  contrast,  one  of  these  clones,  21C3.2F7,  produced  little  IL-2  in 
response  to  anti-T3  or  anti-Ti  stimulation.  The  other  transfected  clones  all 
responded  normally  to  OKT3  and  anti-Ti.  The  basis  for  the  nonresponder 
phenotype is not readily apparent.  It seems unlikely that  the mere presence of 
Thy-1 interfered with T3 activity in 21C3.2F7 cells because the level of surface 
expression of Thy-1.2 was identical in responder and nonresponder transfectants. 
21C3.2F7  has  also  been  shown  to  express  normal  amounts  of T3  and  Ti 
molecules  on  the  cell  surface  (Fig.  2,  and  data  not  shown).  This  clone  can 
certainly produce IL-2, as judged by its response to ionophore and to anti-Thy 
stimulation. When a Thy-1- revertant of this clone was produced, it regained its 
normal  responsiveness  to  OKT3.  These  results  suggest  that  the  re- 
sponder/nonresponder  phenotype is coregulated with Thy-1  expression  in this 
clone. 
Anti-T3  stimulation  of the  nonresponder  clone  led  to  a  clear  increase  in 
[Ca2+]i in  a  Quin  2  assay,  indicating  that  some  of the  signals  associated  with 
receptor  mediated  activation  are  still  occurring.  Therefore,  it  is  somewhat 
paradoxical that stimulation by the Ca 2+ ionophore A23187 and PMA led to IL- 
2 production by the nonresponder Jurkat clone, whereas stimulation by OKT3, 
which resulted in an increase in [Ca2+]i in the absence of a costimulator, failed to 
fully activate  the  cell  in  the  presence  of PMA.  It  is  possible that  ionophore 
induces  pleiotropic  effects  in  cellular  cationic  fluxes  and  that  the  change  in 
[Ca~+]i seen  with  OKT3  is  insufficient  to activate  the  cell.  Alternatively,  this 
particular clone may have a different threshold for responsiveness to [Ca2+]i, and 
ionophore  may be enough  stimulus  to reach  the  threshold,  whereas OKT3  is 
not. 
Although  the  studies  presented  here,  as  well  as  earlier  studies  (9,  31,  32), 
conclusively demonstrate  that  antibodies  to  Thy-1  are  capable  of completely 
inducing the full program of T  cell activation in vitro, the physiological role of 
this molecule in the ontogeny and function of T  cells is not settled. At present 
we  favor  the  view  that  Thy-1  plays  a  critical  role  as  one  of the  alternative 
pathways of T  cell activation. Thus, it would resemble in many respects the T11 
and  9.3 antigens that  have been described on human  lymphocytes. It has been 
proposed (5)  that  T11  may represent  a  phylogenetically primitive  pathway of 
cellular  triggering  which  may have  evolved before the  antigen  specific T  cell 
receptor.  T11  may be particularly  critical  in triggering  thymocyte growth and 
differentiation. It has recently been shown that anti-T 11  mAbs can trigger both 
T3 + and T3- human  thymocytes to express IL-2 receptors, but not to produce 298  Thy-1 EXPRESSION AND  FUNCTION 
IL-2 (33).  It is conceivable that Thy-1 may play a similar role on mouse and rat 
thymocytes, but only remains as an alternative signalling mechanism on mouse 
peripheral T  cells.  It should be emphasized that Thy-1  is a  member of the Ig 
superfamily and that the Ig V region-like domain on Thy-1 may play a receptor- 
like function for a  ligand of similar structure on another cell type, particularly 
during the course of T  cell differentiation in the thymus. Alternatively, Thy-1 
may interact with itself, forming a V to V-like dimer, thereby either creating an 
active site for another transducing protein or forming a  multisubunit Ca  2+ ion 
channel (34). 
Although the physiologic role of Thy-1 remains to be determined, the studies 
presented here demonstrate that a  murine T  cell membrane molecule can be 
expressed on human T  cells with retention of functional properties associated 
with its expression in murine T cells. This system should prove useful in studying 
the  structural  requirements  for  activation  via  Thy-1  and  for  exploring  the 
relationships among the various cell surface and intracellular molecules involved 
in  T  cell  activation.  Furthermore,  our  identification of a  cell  in  which  the 
sequence of events involved in  normal receptor-mediated T  cell triggering is 
reversibly interrupted  may provide  a  valuable  tool  for  the  dissection  of the 
cascade of events seen following antigen recognition. 
Summary 
The  interaction  of certain  mAbs  with  the  Thy-1  molecules  of murine  T 
lymphocytes leads  to cell  activation and proliferation. To  examine the  signal 
transduction mechanism underlying this process and to determine what, if any, 
relationship exists between Thy-l-dependent triggering and T  cell  activation 
mediated through the T3-antigen receptor (T3-Ti) complex, a genomic clone of 
murine  Thy-l.2  was  isolated and  transfected into  the  human  T  cell  tumor, 
Jurkat. The transfected gene was actively transcribed in these human cells and 
high levels of Thy-1,2 glycoprotein were found on the cell membrane. Although 
certain mAbs to Thy-l.2 failed to bind to the Thy-1  transfected Jurkat cells, 
several  known  mitogenic anti-Thy-1  mAbs did  react,  and  in  the presence  of 
phorbol ester, induced IL-2 secretion. One Thy-1 ÷ transfectant out of five failed 
to produce IL-2 in response to anti-T3/Ti antibodies even though it retained 
the ability to increase intracytoplasmic calcium concentration ([Ca2+]i) in response 
to these ligands.  A  Thy-1  negative revertant of this cell regained anti-T3/Ti 
reactivity, suggesting a regulatory defect in signal transmission via T3/Ti in the 
original  transfectant.  These  data  confirm  the  ability  of Thy-1  to  act  as  an 
activation  receptor  for  T  cells.  They  reveal  a  potential  role  for  changes  in 
[Ca2+]i in this process, in common with other pathways of T  cell activation, but 
also indicate a more complex series of events is involved. 
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